N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde

C54H64Cl2N12O7 — CID 172579982

IUPACN-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde
SMILESCC(CC(=O)N1CCC(O)(Cn2cnc3c(-c4ccc(CNCC=O)cc4)n(C)nc3c2=O)CC1)c1ccccc1.CNCCCC(=O)NCCn1ccc(-c2cc(Cl)c(Cl)c3[nH]c4c(c23)CN(C(=O)CO)CC4)n1
InChIInChI=1S/C31H36N6O4.C23H28Cl2N6O3/c1-22(24-6-4-3-5-7-24)18-26(39)36-15-12-31(41,13-16-36)20-37-21-33-27-28(30(37)40)34-35(2)29(27)25-10-8-23(9-11-25)19-32-14-17-38;1-26-6-2-3-19(33)27-7-10-31-9-5-18(29-31)14-11-16(24)22(25)23-21(14)15-12-30(20(34)13-32)8-4-17(15)28-23/h3-11,17,21-22,32,41H,12-16,18-20H2,1-2H3;5,9,11,26,28,32H,2-4,6-8,10,12-13H2,1H3,(H,27,33)
InChIKeyMHARNHNICGWTKH-UHFFFAOYSA-N
MW1064.09 g/mol
LogP4.96
Rot. Bonds19

About N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde

N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde (PubChem CID 172579982) has the molecular formula C54H64Cl2N12O7 and a molecular weight of 1064.09 g/mol. Its IUPAC name is N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde.

Molecular Properties

Compound NameN-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde
PubChem CID172579982
Molecular FormulaC54H64Cl2N12O7
Molecular Weight1064.09 g/mol
Exact Mass1062.44
IUPAC NameN-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde
SMILESCC(CC(=O)N1CCC(O)(Cn2cnc3c(-c4ccc(CNCC=O)cc4)n(C)nc3c2=O)CC1)c1ccccc1.CNCCCC(=O)NCCn1ccc(-c2cc(Cl)c(Cl)c3[nH]c4c(c23)CN(C(=O)CO)CC4)n1
InChIInChI=1S/C31H36N6O4.C23H28Cl2N6O3/c1-22(24-6-4-3-5-7-24)18-26(39)36-15-12-31(41,13-16-36)20-37-21-33-27-28(30(37)40)34-35(2)29(27)25-10-8-23(9-11-25)19-32-14-17-38;1-26-6-2-3-19(33)27-7-10-31-9-5-18(29-31)14-11-16(24)22(25)23-21(14)15-12-30(20(34)13-32)8-4-17(15)28-23/h3-11,17,21-22,32,41H,12-16,18-20H2,1-2H3;5,9,11,26,28,32H,2-4,6-8,10,12-13H2,1H3,(H,27,33)
InChIKeyMHARNHNICGWTKH-UHFFFAOYSA-N
XLogP4.96
TPSA237.63 Ų
H-Bond Donors6
H-Bond Acceptors15
Rotatable Bonds19
Heavy Atoms75
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001064.09
LogP ≤ 54.96
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde?
The IUPAC name of N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde (CID 172579982) is N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde.
What is the SMILES notation for N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde?
The canonical SMILES for N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde is CC(CC(=O)N1CCC(O)(Cn2cnc3c(-c4ccc(CNCC=O)cc4)n(C)nc3c2=O)CC1)c1ccccc1.CNCCCC(=O)NCCn1ccc(-c2cc(Cl)c(Cl)c3[nH]c4c(c23)CN(C(=O)CO)CC4)n1.
What is the InChIKey of N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde?
The InChIKey is MHARNHNICGWTKH-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H36N6O4.C23H28Cl2N6O3/c1-22(24-6-4-3-5-7-24)18-26(39)36-15-12-31(41,13-16-36)20-37-21-33-27-28(30(37)40)34-35(2)29(27)25-10-8-23(9-11-25)19-32-14-17-38;1-26-6-2-3-19(33)27-7-10-31-9-5-18(29-31)14-11-16(24)22(25)23-21(14)15-12-30(20(34)13-32)8-4-17(15)28-23/h3-11,17,21-22,32,41H,12-16,18-20H2,1-2H3;5,9,11,26,28,32H,2-4,6-8,10,12-13H2,1H3,(H,27,33).
What are the key properties of N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde?
N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde has a molecular weight of 1064.09 g/mol, XLogP of 4.96, 19 rotatable bonds, 6 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[3-[6,7-dichloro-2-(2-hydroxyacetyl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-9-yl]pyrazol-1-yl]ethyl]-4-(methylamino)butanamide;2-[[4-[6-[[4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methylamino]acetaldehyde is sourced from PubChem (CID 172579982), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).